Photo

Avanir Restructures, Will Cut 11% of US Workforce

Avanir Pharmaceuticals Inc. will lay off 73 employees by the end of January from its US work force as part of a restructuring. We’re told the majority will be outside of its Aliso Viejo headquarters.

FDA Approves Avanir Migraine Drug

Aliso Viejo-based Avanir Pharmaceuticals Inc. said today that the Food and Drug Administration approved its Onzetra Xsail drug for treating adults’ acute migraine headache.

Avanir Names New Chief

Avanir Pharmaceuticals Inc., an Aliso Viejo-based drugmaker, said today that Rohan Palekar is its new chief executive.

Avanir to be Acquired for $3.5B

Avanir Pharmaceuticals Inc. has agreed to be acquired by Otsuka Pharmaceutical Co. for $3.5 billion.

Avanir Selling $200 Million in Stock

Aliso Viejo-based Avanir Pharmaceuticals Inc. is offering $200 million of its shares to the general public.

Avanir Shares Up on Positive Trial Data

Aliso Viejo-based Avanir Pharmaceuticals Inc.’s shares rose today on positive clinical trial results for a potential Alzheimer’s disease treatment.

Sections